Carlsmed (CARL)Officer filed to sell ~$11K
Bertolini Jeffrey, Officer at Carlsmed, filed to sell ~$11K of Carlsmed shares.
- ~$11K
- planned to sell · 747 shares, around Oct 5, 2026
- Planned for
- Oct 5, 2026
- Notice filed
- Oct 5, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 24, 2025Insider10% owner purchased ~$3M of CARL shares in the open market
- Sep 4, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 4, 2026, the Board of Directors of Carlsmed, Inc. (the “Company”) appointed Jeffrey Bertolini as Chief Operating Officer of the Company, effective September 8, 2026.”
- Sep 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 28, 2026, Carlsmed, Inc. (the “Company”) announced that Leo Greenstein has departed his role as the Company’s Chief Financial Officer, effective September 25, 2026 (the “Separation Date”).”
- Sep 24, 2026FDAFDA device clearance: corra® cervical plating system
- Sep 30, 2026InsiderOfficer sold ~$3.4K of CARL shares in the open market
- Oct 5, 2026InsiderOfficer sold ~$11K of CARL shares in the open market
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Carlsmed
For Carlsmed, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CARL page.
How this filing works
Other disclosures at Carlsmed
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 4Sep 16, 2026
- SEC Form 4Mar 5, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 4Jul 25, 2025
Everything OQRO holds on this company is on its CARL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
